The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ALMB-0168, a novel Cx43 hemichannel agonist monoclonal antibody, for metastatic or unresectable osteosarcoma after standard chemotherapy: A multicenter, open-label, single-arm, phase 1 study.
 
Jingnan Shen
No Relationships to Disclose
 
Wei Guo
No Relationships to Disclose
 
Jin Wang
No Relationships to Disclose
 
Xianbiao Xie
No Relationships to Disclose
 
Lu Xie
No Relationships to Disclose
 
Jie Xu
No Relationships to Disclose
 
Chen Jing
No Relationships to Disclose
 
Jianhua Lin
No Relationships to Disclose
 
Xianan Li
No Relationships to Disclose
 
Yong Zhou
No Relationships to Disclose
 
Guowen Wang
No Relationships to Disclose
 
Xiaojing Zhang
No Relationships to Disclose
 
Yao Weitao
No Relationships to Disclose
 
Yang Dong
No Relationships to Disclose
 
Zhaoming Ye
No Relationships to Disclose
 
Li Wang
Employment - CSPC Pharmaceutical Group
 
Yanyan Zeng
Employment - CSPC Pharmaceutical Group
 
Yongyong Wu
Employment - CSPC Pharmaceutical Group
 
Xiugao Yang
Employment - CSPC Pharmaceutical Group
 
Yanfeng Zhang
Employment - AlaMab Therapeutics